The invention relates to the use of MIA to prevent inflammatory diseases and in particular their use in treatment of chronic destruction of articular cartilage. More specifically, MIA can be used to induce specific T-cell tolerance to the MIA antigen in patients suffering from rheumatoid arthritis.
展开▼